1. Home
  2. USLM vs EVO Comparison

USLM vs EVO Comparison

Compare USLM & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

USLM

United States Lime & Minerals Inc.

N/A

Current Price

$111.72

Market Cap

3.3B

Sector

Industrials

ML Signal

N/A

Logo Evotec SE

EVO

Evotec SE

N/A

Current Price

$1.66

Market Cap

568.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
USLM
EVO
Founded
1948
1993
Country
United States
Germany
Employees
N/A
N/A
Industry
Other Metals and Minerals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
568.6M
IPO Year
1994
2007

Fundamental Metrics

Financial Performance
Metric
USLM
EVO
Price
$111.72
$1.66
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
★ $4.17
AVG Volume (30 Days)
107.3K
★ 153.5K
Earning Date
10-28-2026
11-05-2026
Dividend Yield
★ 0.22%
N/A
EPS Growth
★ 23.22
N/A
EPS
★ 2.26
N/A
Revenue
★ $144,435,000.00
N/A
Revenue This Year
$11.88
N/A
Revenue Next Year
$13.43
$20.51
P/E Ratio
$49.27
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$96.27
$1.50
52 Week High
$141.44
$4.27

Technical Indicators

Market Signals
Indicator
USLM
EVO
Relative Strength Index (RSI) 46.58 46.64
Support Level $102.60 $1.50
Resistance Level $114.22 $1.97
Average True Range (ATR) 3.02 0.05
MACD -0.23 0.02
Stochastic Oscillator 52.24 76.00

Price Performance

Historical Comparison
USLM
EVO

About USLM United States Lime & Minerals Inc.

United States Lime & Minerals Inc is engaged in the business of manufacturing lime and limestone products including PLS, quicklime, hydrated lime and lime slurry. The company supplies its products predominantly to the construction including highway, road, and building contractors, industrial including paper and glass manufacturers, environmental including municipal sanitation and water treatment facilities and flue gas treatment processes, metals including steel producers, oil and gas services, roof shingle manufacturers and agriculture including poultry industries. The company operates through its Lime and Limestone Operations segment.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: